Latest Share Purchase Plan News

Larvotto Resources has successfully raised $60 million in equity alongside a $105 million bond, fully funding the Hillgrove Antimony-Gold Mine development with production targeted for mid-2026.

QuickFee Limited reports a record A$7.2 million quarterly revenue, driven by strong US and Australian growth, alongside positive underlying profitability and a major refinancing.

FireFly Metals has identified 325 promising geophysical targets at its Green Bay copper-gold project in Newfoundland, using advanced airborne surveys, and is accelerating drilling with strong financial backing.

New Murchison Gold Limited has transitioned from explorer to producer with mining underway at its Crown Prince project, backed by a $12 million capital raise and promising high-grade drilling results.

Australian Strategic Materials has successfully closed an oversubscribed Share Purchase Plan, raising nearly A$12 million at a 20% discount to recent market prices.

Amplia Therapeutics has launched a $27.5 million capital raising to advance its lead drug Narmafotinib, a promising FAK inhibitor showing superior efficacy in pancreatic cancer trials. The funds will support ongoing and new clinical studies, positioning the company for pivotal regulatory milestones.

Amplia Therapeutics has successfully raised A$25 million through an institutional placement and launched a A$2.5 million Share Purchase Plan to fund pivotal clinical trials of its lead drug narmafotinib. The capital injection positions the company to advance key pancreatic and ovarian cancer studies into 2027.

QPM Energy has successfully raised $7 million through an oversubscribed Share Purchase Plan, significantly exceeding its initial $2 million target to accelerate key gas power projects in Queensland.

Australian Strategic Materials (ASM) reports significant progress in Q2 2025, including its first commercial heavy rare earth metals sale and a transformative low-cost production pathway at its Dubbo Project.

Miramar Resources has announced a $1 million Share Purchase Plan to fast-track drilling at its promising 8 Mile gold prospect near Kalgoorlie, following recent significant mineralisation discoveries.

Prescient Therapeutics has extended the closing date of its Share Purchase Plan to July 25, 2025, responding to shareholder demand and reinforcing strong participation. The oncology-focused biotech also highlights upcoming clinical milestones and ongoing investor engagement.

Strike Energy has announced a strategic placement and share purchase plan raising up to A$103 million to advance its core Perth Basin gas projects, backed by a significant investment from Carnarvon Energy. This funding underpins key developments targeting first production by late 2026 and a final investment decision for West Erregulla.